文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 基础医学 > 综述
侵权投诉

综述

Current Drug Discovery Technologies, 2010, 7, 37-45 37

Traditional Chinese Medicines (TCMs) for Molecular Targeted Therapies of Tumours

Mahmoud Youns1,2, Jörg D. Hoheisel3 and Thomas Efferth*,1

Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg 5, 55128 Mainz, Germany; 2Department of Biochemistry, Faculty of Pharmacy, University of Helwan, Ain Helwan, 11795 Cairo, Egypt; 3Functional Genome Analysis, German Cancer Research Centre (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany

Abstract: Scientific progress in genetics, cell and molecular biology has greatly ameliorated our comprehensive under-standing of the molecular mechanisms of neoplastic transformation and progression. The rapidly advancing identification of molecular targets in human cancers during the last decade has provided an excellent starting point for the development of novel therapeutics. A huge variety of potential molecular targets have been identified, many of which are already in the market for therapeutic purposes. It is now becoming possible to target pathways and/or molecules that are crucial in main-taining the malignant phenotype. Traditional Chinese medicine (TCM) is often considered as alternative or complemen-tary medicine. TCM represents a holistic approach and lacks high-quality scientific evidence on its effectiveness. There-fore, it is frequently regarded with some scepticism by western academic medicine. In this review, we report that applica-tion of modern technologies allowed identification of novel molecular targets modulating the anti-tumour activity of natu-ral products derived from TCM. Moreover, we tried to cross the bridge between TCM and Western modern medicine to be able to implement them for the sake of cancer patients.

1

Key Words: TCM, tumour, artesunate, berberine, cantharidin, arsenic trioxide, curcumin. INTRODUCTION

Cancer is the second-leading cause of death among hu-mans [1] and is responsible for one in eight deaths world-wide [2]. It is characterized by unrestrained proliferation of cells that can invade beyond normal tissue boundaries and metastasize to distant organs [2]. A total of 1,479,350 new cancer cases and 562,340 deaths from cancer are expected to occur in the United States in 2009 [3]. This underscores a desperate need for improved therapeutic options with an ac-ceptable therapeutic index.

In the late 1980s, molecular and genetic approaches for the understanding of cell biology brought to light new sig-nalling networks that regulate cellular activities such as pro-liferation and survival. These included cytoplasmic signal-ling molecules, nuclear cell cycle proteins, membrane growth factors receptors, modulators of apoptosis and mole-cules that promote angiogenesis [4]. The beginning of a new “targeted therapy era” started in the late 1990s, where a greater amount of drugs targeted at these key proteins were developed and interestingly transformed cancer drug devel-opment [5]. The development of imatinib mesylate (Gleevec), a small molecule inhibitor that competes with ATP and inhibits BCR-ABL tyrosine kinase activity, was seminal during this period. The Food and Drug Administra-tion (FDA) approved this drug for the treatment of chronic

*Address correspondence to this author at the Department of Pharmaceuti-cal Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg 5, 55128 Mainz, Germany; Tel: +49-6131-39-25751; Fax: +49-6131-3923752; E-mail: efferth@uni-mainz.de

myeloid leukaemia (CML) in 2001 based on its high re-sponse rates [6].

MOLECULAR TARGETS AS CANCER THERAPEU-TICS

Recently, there has been an increasing and rapid devel-opment of molecular candidate markers as targets for inno-vative therapeutic concepts (Targeted Therapy). A high number of molecules have become novel therapeutic targets already, especially tumour-associated antigens, growth fac-tors and growth factor receptors, molecules of signal trans-duction, molecules of intracellular protein metabolism (pro-teasome inhibitors), factors regulating cell survival, cell cy-cle and cell death, and molecules associated with invasion, metastasis and angiogenesis [7]. Some of these molecular targeted compounds are not only efficient as tumour thera-peutics, but also could improve the patient’s quality of life by, for example, reducing pain associated with the reduction of bone by using compounds such as zoledronic acid [7-11]. A day by day, the list of targets for molecular therapy is growing. In this review, we will select representative exam-ples of natural products derived from traditional Chinese medicine (TCM) along with a particular focus on their re-cently discovered molecular targets modulating their effects as anti-tumour agents.

NATURAL PRODUCTS AND CANCER TREATMENT Natural products are among the major key players in pharmacology in general and in cancer research in particular. A considerable portion of anti-tumour agents currently used in the clinic are of natural origin. Naturally occurring anti-天然植物

© 2010 Bentham Science Publishers Ltd.

1570-1638/10 $55.00+.00

第1页

你可能喜欢

热门文档

相关文档

  • 文献综述模板(超强整合)

    文献综述模板(超强整合)_总结/汇报_实用文档。综述文献综述模板(超强整合) 文献综述(论文标题,小二号,黑体,居中) 姓名 摘要:内容??( “摘要: ”两个字要求是黑...

  • 医学综述论文范文汇总_综述医学论文范文

    医学综述论文范文汇总_综述医学论文范文_临床医学_医药卫生_专业资料。医学综述论文范文汇总 卒中后抑郁的心理护理观察 【摘要】 目的:观察心理护理对卒中后抑郁患者的...

  • 毕业论文文献综述范文-论文

    毕业论文文献综述范文-论文_其它_高等教育_教育专区。毕业论文文献综述范文-论文毕业论文文献综述范文毕业论文文献综述参考范文 毕业设计(论文)文献综述 题目名称 在高校...

  • 文献综述该怎么写(有范例)

    文献综述该怎么写(有范例)_文学研究_人文社科_专业资料。写毕业论文时用得到,里面有具体的例子,课题国内外研究现状述评文献综述该怎么写? ——文献综述写作技巧何为...

  • 文献综述格式、范文及书写规范要求

    文献综述格式、范文及书写规范要求_调查/报告_表格/模板_实用文档。文献综述格式、范文及书写规范要求 一、 定义: 综述是指就某一时间内,作者针对某一专题,对大量原...

  • 综述格式

    现金股利政策影响因素研究综述 姓名 颜翌佳(专业:金融 班级:1103 学号:1103010328) 内容摘要: 对上市公司股利政策的研究是现代财务学界的核心问题之一。 本文 通过...

  • 综述范文

    文献综述格式及写作技巧( 文献综述格式及写作技巧(附文献综述 范文) 范文)文献综述是在对文献进行阅读、选择、比较、分类、分析和 综合的基础上, 研究者用自己的...

  • 综述文格式

    如何撰写综述性论文 第一部分 什么是综述? 综述,其中综是综合,述,更多的不是叙述,而是评述和述评。只评述还不够,还要就观点、材料和方法进行综述。“综”是要求...

  • 综述格式字体等

    综述格式字体等_医药卫生_专业资料。综述题目(居中,宋体,四号,加粗) 综述题目(居中,宋体,四号,加粗) 作者姓名(居中,楷体,五号,多作者以 “,” 分隔) 综述 (...

  • 专业综述

    HEFEI UNIVERSITY 自动化专业综述 题系班姓学 目别级名号 自动化专业综述 电子信息与电气工程系 年少轻狂 完成 时间 2011 年 5 月 1 日 自动化专业综述通过...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email